Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (5): 805-810. doi: 10.19723/j.issn.1671-167X.2018.05.007

• Article • Previous Articles     Next Articles

Clinicopathological analysis of patients with papillary renal cell carcinoma complicated by tumor thrombus

DING Zhen-shan,QIU Min,XU Zi-cheng,XIAO Ruo-tao,GE Li-yuan,MA Lu-lin△   

  1. (Department of Urology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2018-10-18 Published:2018-10-18
  • Contact: MA Lu-lin E-mail:malulin@medmail.com.cn

Abstract: Objective: To investigate the clinicopathological features,treatment and prognosis of patients with papillary renal cell carcinoma (PRCC) and PRCC-complicated with tumor thrombus. Me-thods: Single center retrospective analysis of 75 patients with PRCC treated from January 2012 to October 2017 was performed. There were 55 males and 20 females at an age range of 24-82 years. Sixteen PRCC patients were complicated with tumor thrombus. All the patients were with a surgery and had clear pathological diagnosis and detailed follow-up data. The clinicopathological features,prognosis and influencing factors of the patients with PRCC and PRCC complicated with tumor thrombus were analyzed and summarized. Results: The average age of the 75 patients was(56.05±11.59)years,the average body mass index (BMI) was (26±3) kg/m2, and the average tumor maximum diameter was(5.17±3.85)cm. There were significant differences between tumor maximum diameter larger than 7 cm and less than 7 cm (69.6% vs. 94.4%, P<0.001), lymph node metastasis and no lymph node metastasis (<38% vs. 98%, P<0.001), adrenal metastasis and no adrenal metastasis (0% vs. 95.3%, P<0.001), pulmonary metastasis and no pulmonary metastasis (0% vs.90.7%, P<0.001), complicated with and without tumor thrombus (<66.4% vs. 93.5%, P<0.001) on the effect of 3-year survival rate of the PRCC patients. In this study, there were 16 patients with type 2 PRCC complicated with tumor thrombus. There were significant differences in concomitant symptoms (62.5% vs. 22.0%, P=0.005), maximum tumor diameter (68.8% vs.13.3%, P<0.001), adrenal metastasis (18.8% vs. 0.02%, P=0.029), pulmonary metastasis (18.8% vs. 0%, P=0.008), nuclear grade (P<0.001) and pathological type (100% vs. 44.1%, P<0.001) between the PRCC patients with  and  without tumor thrombus. Conclusion: There were significant differences in tumor diameter,lymph node metastasis,adrenal metastasis,pulmonary metastasis,pathological type,nuclear grade and tumor thrombus in the effect of the 3year survival rate of PRCC patients. PRCC patients with tumor thrombus were more commonly suffered from type 2 PRCC, for whom the tumor diameter was larger,the nuclear grade was higher,and the distance metastasis happened more easily.

Key words: Papillary renal cell carcinoma, Tumor thrombus, Survival rate

CLC Number: 

  • R737.1
[1] Yu TIAN,Xiao-yue CHENG,Hui-ying HE,Guo-liang WANG,Lu-lin MA. Clinical and pathological features of renal cell carcinoma with urinary tract tumor thrombus: 6 cases report and literature review [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 928-932.
[2] HONG Peng,TIAN Xiao-jun,ZHAO Xiao-yu,YANG Fei-long,LIU Zhuo,LU Min,ZHAO Lei,MA Lu-lin. Bilateral papillary renal cell carcinoma following kidney transplantation: A case report [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 811-813.
[3] ZHAO Xun,YAN Ye,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,ZHANG Hong-xian,LIU Cheng,MA Lu-lin. Influence of deep invasive tumor thrombus on the surgical treatment and prognosis of patients with non-metastatic renal cell carcinoma complicated with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 665-670.
[4] Lei LIU,Guo-liang WANG,Lu-lin MA,Min LU,Cheng LIU,Xiao-fei HOU. Diagnosis and surgical treatment of massive adrenal area tumor with tumor thrombus [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 684-688.
[5] Li-wei LI,Zhuo LIU,Guo-liang WANG,Hua ZHANG,Wen CHEN,Jing MA,Li ZHANG,Wei HE,Lu-lin MA,Shu-min WANG. Comparison of various imaging in the diagnosis of renal cell carcinoma with inferior vena cava tumor thrombus combined with bland thrombus [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 678-683.
[6] YE Jian-fei, MA Lu-lin, ZHAO Lei, WANG Guo-liang. Segmental vena cava resection for the treatment of renal tumor with invading tumor thrombus [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 183-187.
[7] ZENG Hong, RONG Xiao-ying, ZHANG Xiao-qing, GUO Xiang-yang. Application of intraoperative cell salvage combined with leukocyte depletion filter on radical nephrectomy for renal carcinoma with inferior vena cava tumor thrombus:2 case reports#br# [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 736-739.
[8] LIU Zhuo, MA Lu-lin, TIAN Xiao-jun, WANG Guo-liang, HOU Xiao-fei, ZHANG Shu-dong, DENG Shao-hui. Radical nephrectomy and thrombectomy for Mayo clinic stage Ⅲ tumor thrombus: a surgical technique and clinical experience [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 597-602.
[9] ZHANG Feng-Bo, DU Yuan, SHAO Qiang, TIAN Ye. Treatment of local low/intermediate risk prostate cancer with low dose rate brachytherapy: a report of 133 cases at a single center [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 611-614.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 505 -515 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .